Peter Nordberg
AstraZeneca (Finland)(FI)AstraZeneca (Sweden)(SE)
Publications by Year
Research Areas
RNA Interference and Gene Delivery, Advanced biosensing and bioanalysis techniques, Synthesis and Reactions of Organic Compounds, Protein Kinase Regulation and GTPase Signaling, DNA and Nucleic Acid Chemistry
Most-Cited Works
- → The mechanism of action of the antisecretory agent omeprazole(1986)306 cited
- → Functionalized lipid nanoparticles for subcutaneous administration of mRNA to achieve systemic exposures of a therapeutic protein(2021)86 cited
- → Structural basis for the binding of naproxen to human serum albumin in the presence of fatty acids and the GA module(2008)63 cited
- → Chemical Reactions of Omeprazole and Omeprazole Analogues. I. A Survey of the Chemical Transformations of Omeprazole and its Analogues.(1989)60 cited
- → Discovery of AZD2716: A Novel Secreted Phospholipase A2 (sPLA2) Inhibitor for the Treatment of Coronary Artery Disease(2016)41 cited
- → Inhibition of gastric H+/K+-ATPase by substituted imidazo[1,2-α]pyridines(1988)28 cited
- → Identification of Mineralocorticoid Receptor Modulators with Low Impact on Electrolyte Homeostasis but Maintained Organ Protection(2018)20 cited
- → Chemical Reactions of Omeprazole and Omeprazole Analogues. V. The Reaction of N-Alkylated Derivatives of Omeprazole Analogues with 2-Mercaptoethanol.(1989)18 cited
- → Crystal structure of a bacterial albumin‐binding domain at 1.4 Å resolution(2007)16 cited
- → Discovery of a Series of Indole-2 Carboxamides as Selective Secreted Phospholipase A2 Type X (sPLA2-X) Inhibitors(2018)12 cited